Tech Company Financing Transactions
ContraFect Funding Round
ContraFect closed a $2 million funding round on 9/5/2013. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/5/2013
Transaction Type
Debt
Amount
$1,966,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
28 Wells Ave.
Yonkers, NY 10701
USA
Yonkers, NY 10701
USA
Phone
Website
Email Address
Overview
We are a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roger Pomerantz
Chief Medical Officer
Cara Cassino
VP - Finance
Nancy Dong
VP - Finance
Michael Messinger
VP - General Counsel
Natalie Bogdanos
Browse more venture capital transactions:
Prev: 9/5/2013: Respicardia venture capital transaction
Next: 9/5/2013: Arsenal Medical venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs